Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections

BACKGROUND: Delafloxacin is an oral or intravenous (IV) antibiotic indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI), including both gram-positive (including methicillin-resistant Staphylococcus aureus [MRSA]) and gram-negative organisms. Chemically distinct...

Descripción completa

Detalles Bibliográficos
Autores principales: Giordano, Philip A, Pogue, Jason M, Cammarata, Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452004/
https://www.ncbi.nlm.nih.gov/pubmed/30957167
http://dx.doi.org/10.1093/cid/ciz006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452004/
https://www.ncbi.nlm.nih.gov/pubmed/30957167
http://dx.doi.org/10.1093/cid/ciz006

Ejemplares similares